Cisplatin-induced downregulation of OCTN2 affects carnitine wasting - Wikidata - wikimedia - TriplyDB

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

http://www.wikidata.org/entity/Q36491674

about

Membrane transporters as mediators of Cisplatin effects and side effects.Cisplatin-induced renal injury is independently mediated by OCT2 and p53.Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers Contribution of tumoral and host solute carriers to clinical drug response.L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial Inhibition of OCTN2-mediated transport of carnitine by etoposide.Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy Polymorphic transporters and platinum pharmacodynamics Uptake carriers and oncology drug safety.l-carnitine and cancer cachexia: Clinical and experimental aspects.Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature.The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.Renal Drug Transporters and Drug Interactions.Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity.Carnitine and Adiponectin Levels in Breast Cancer after Radiotherapy.

P2860

Q30446860-F0DFA85E-69C9-41C8-A580-44FD9BDD5307 Q33992572-2A656B96-D0DF-4996-88FF-D26B9ECEA44F Q34820601-FCEF53B5-5DE7-4D08-878A-38FB1586F25A Q35946876-B48222B6-3053-4C2C-AD75-B337E80A6034 Q36226621-7E2ADAAA-68B1-4103-9939-B932B74F2AA8 Q36302949-F7817FFB-0FF1-4A83-B305-805DF751A93D Q36352809-135FC2D6-44D6-45EA-98D2-1606809DE5CA Q36995742-E3904C4D-667E-4376-AA69-D588F33D05B2 Q37663396-370AD31A-5727-4BB3-9D92-FA14B70A7F36 Q37863019-1A97A622-BD5D-4119-826F-2A1BB73B0E77 Q38090981-CFC14DE9-17C1-4A6B-A06A-12EAB1691AF4 Q38105163-17EFF69F-5D63-49D9-9103-904917E934AA Q38888345-59860F22-E41E-43B7-AF73-CA4B217A0B58 Q39140289-C8532480-0310-4E2F-A806-0C29CE758352 Q47344383-D892BBAC-6218-4ADB-A68B-8AA8E2CAB144 Q54956669-0BCF0FEA-64B0-4BC2-AA1B-7636DCE10185

P2860

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

http://www.wikidata.org/entity/Q36491674

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

@ast

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

@en

type

label

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

@ast

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

@en

prefLabel

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

@ast

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

@en

P1433

Q36491674-E6AD512D-4D1C-45AC-9D8C-A8683408C74D

P1476

Q36491674-A3DD185B-B9AC-4BC2-8D3B-487DA1D535EA

P2093

Q36491674-05253986-5727-473B-ABE1-8C48CCBB905A

Q36491674-15578CE2-700B-4745-9D31-7279720E6C7B

Q36491674-472AC7BD-C9C8-4CE1-8FD1-887F7F6DC6E5

Q36491674-6F39558E-5189-422A-A4C5-933858648DE2

Q36491674-7E79E094-3635-4688-ACF7-B45F762DDEF9

Q36491674-BBDC1C59-7CDB-4A56-B27F-95CA8BF09B11

Q36491674-C4F9320E-E6D5-4293-B20C-CC4F1BC61366

Q36491674-F848E429-312C-424D-B590-9B745BC53C35

P2860

Q36491674-024E77DC-69C2-4D70-9D58-9D15E87A5466

Q36491674-13D79FCB-FE7C-4CD3-8828-8CC149938446

Q36491674-1A9ABC51-A823-4D61-85E7-AB7A18D2165E

Q36491674-1E0C2490-91D2-494B-8727-A7B136B739A8

Q36491674-1E4FD540-2E11-4337-B40C-27BE74DF31B3

Q36491674-28818BB5-DE8E-4B59-9385-CA51D243CECF

Q36491674-32E30E54-D941-40D8-8A03-1E1BA47377DB

Q36491674-338D5835-949D-4CA5-ADAD-62D8DFE45BE0

Q36491674-4D0C0814-E401-41E1-8186-623ADA5D9BBD

Q36491674-4F1A5046-0F39-4F21-8A2D-F8B71223FD4B

P304

Q36491674-C7A71343-F7F3-4A48-A5BC-0E6FC7DA2AE3

P31

Q36491674-A74EED1B-2993-46F6-B077-106DE7701D77

P356

Q36491674-7D897315-69EF-41D8-BF70-7B1FC7AB1E83

P407

Q36491674-BD7F82FA-D8DF-4669-A2A1-327F3352AFAF

P433

Q36491674-F3AF950D-8579-4459-A82B-BE7969A59DCF

P478

Q36491674-4777987A-D2DA-4EB1-8B4B-1B1C80CE22C5

P50

Q36491674-3E2558F4-E661-4278-BACF-3FEA28693492

P577

Q36491674-EFA1F70F-AFF8-4795-AC50-3579B03947A7

P5875

Q36491674-69019D59-C187-449E-9CC0-10C9F6812F1D

P698

Q36491674-1D91A348-E12A-485A-86EF-6ADDA1FC749D

P932

Q36491674-921E344B-153F-4127-975E-B00FF7B1CD9B

P356

1078-0432.CCR-10-1239

P1433

Clinical Cancer Research

P1476

Cisplatin-induced downregulation of OCTN2 affects carnitine wasting

@en

P2093

Chaoxin Hu

http://www.w3.org/2001/XMLSchema#string

Cynthia S Lancaster

http://www.w3.org/2001/XMLSchema#string

Kelly K Filipski

http://www.w3.org/2001/XMLSchema#string

Ryan M Franke

http://www.w3.org/2001/XMLSchema#string

Shelley J Orwick

http://www.w3.org/2001/XMLSchema#string

Walter J Loos

http://www.w3.org/2001/XMLSchema#string

Zhaoyuan Chen

http://www.w3.org/2001/XMLSchema#string

Zhili Zuo

http://www.w3.org/2001/XMLSchema#string

P2860

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Amino acid substitution matrices from protein blocks

Disorders of carnitine transport and the carnitine cycle

Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli

AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR

Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function

Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter

Carnitine deficiency induced by pivampicillin and pivmecillinam therapy

Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter

P304

4789-4799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-1239

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Alex Sparreboom

P577

2010-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46393247

http://www.w3.org/2001/XMLSchema#string

P698

20858838

http://www.w3.org/2001/XMLSchema#string

P932

3531239

http://www.w3.org/2001/XMLSchema#string